{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:55:22Z","timestamp":1771577722517,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,11,17]],"date-time":"2007-11-17T00:00:00Z","timestamp":1195257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1245\/s10434-007-9622-2","type":"journal-article","created":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T15:41:01Z","timestamp":1195227661000},"page":"452-461","source":"Crossref","is-referenced-by-count":23,"title":["MRI Screening in a Clinic Population with a Family History of Breast Cancer"],"prefix":"10.1245","volume":"15","author":[{"given":"Jeanne","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Liberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick I.","family":"Borgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,17]]},"reference":[{"issue":"3","key":"9622_CR1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3322\/canjclin.56.3.168","volume":"56","author":"C Smigal","year":"2006","unstructured":"Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: Update 2006. CA Cancer J Clin 2006; 56(3):168\u201383.","journal-title":"CA Cancer J Clin"},{"issue":"24","key":"9622_CR2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81(24):1879\u201386.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"9622_CR3","first-page":"467","volume":"10","author":"JM Satagopan","year":"2001","unstructured":"Satagopan JM, Offit K, Foulkes W, et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 2001; 10(5):467\u201373.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"9622_CR4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312(3):146\u201351.","journal-title":"N Engl J Med"},{"issue":"12","key":"9622_CR5","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","volume":"22","author":"DL Page","year":"1991","unstructured":"Page DL, Kidd TE Jr., Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22(12):1232\u20139.","journal-title":"Hum Pathol"},{"issue":"6","key":"9622_CR6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2","volume":"79","author":"AC Aisenberg","year":"1997","unstructured":"Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willett CG. High risk of breast carcinoma after irradiation of young women with Hodgkin\u2019s disease. Cancer 1997; 79(6):1203\u201310.","journal-title":"Cancer"},{"issue":"3","key":"9622_CR7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-004-2172-4","volume":"89","author":"M Lacroix","year":"2005","unstructured":"Lacroix M, Leclercq G. The \u201cportrait\u201d of hereditary breast cancer. Breast Cancer Res Treat 2005; 89(3):297\u2013304.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"9622_CR8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","volume":"24","author":"S Chen","year":"2006","unstructured":"Chen S, Iversen ES, Friebel T, et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 2006; 24(6):863\u201371.","journal-title":"J Clin Oncol"},{"issue":"18","key":"9622_CR9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90(18):1371\u201388.","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"9622_CR10","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1001\/jama.283.23.3068g","volume":"283","author":"D Schrag","year":"2000","unstructured":"Schrag D, Kuntz KM, Garber JE, Weeks JC. Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations. JAMA 2000; 283(23):3070\u20132.","journal-title":"JAMA"},{"issue":"3","key":"9622_CR11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2214\/ajr.181.3.1810619","volume":"181","author":"EA Morris","year":"2003","unstructured":"Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003; 181(3):619\u201326.","journal-title":"AJR Am J Roentgenol"},{"key":"9622_CR12","doi-asserted-by":"crossref","unstructured":"Cronin KA, Feuer EJ, Clarke LD, Plevritis SK. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: Comparison of mortality results from the cisnet breast cancer base case analysis. J Natl Cancer Inst Monogr 2006; (36):112\u201321.","DOI":"10.1093\/jncimonographs\/lgj015"},{"issue":"2","key":"9622_CR13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57(2):75\u201389.","journal-title":"CA Cancer J Clin"},{"key":"9622_CR14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1245\/s10434-006-9195-5","volume":"14","author":"ER Port","year":"2007","unstructured":"Port ER, Park A, Borgen PI, Morris E, Montgomery LL. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 2007; 14:1051\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"9622_CR15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2214\/ajr.178.5.1781211","volume":"178","author":"EA Morris","year":"2002","unstructured":"Morris EA, Liberman L, Dershaw DD, et al. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol 2002; 178(5):1211\u201320.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"9622_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2214\/ajr.179.1.1790171","volume":"179","author":"L Liberman","year":"2002","unstructured":"Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: Features and positive predictive value. AJR Am J Roentgenol 2002; 179(1):171\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"5 Part 1","key":"9622_CR17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7326\/0003-4819-137-5_Part_1-200209030-00012","volume":"137","author":"LL Humphrey","year":"2002","unstructured":"Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137(5 Part 1):347\u201360.","journal-title":"Ann Intern Med"},{"key":"9622_CR18","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1200\/JCO.2004.00.4960","volume":"23","author":"CK Kuhl","year":"2005","unstructured":"Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005; 23:8469\u201376.","journal-title":"J Clin Oncol"},{"key":"9622_CR19","first-page":"115","volume":"21","author":"F Podo","year":"2002","unstructured":"Podo F, Sardanelli F, Canese R, et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002; 21:115\u201324.","journal-title":"J Exp Clin Cancer Res"},{"key":"9622_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1006480106487","volume":"63","author":"MM Tilanus-Linthorst","year":"2000","unstructured":"Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 2000; 63:53\u201360.","journal-title":"Breast Cancer Res Treat"},{"key":"9622_CR21","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/cncr.20971","volume":"103","author":"CD Lehman","year":"2005","unstructured":"Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005; 103:1898\u201305.","journal-title":"Cancer"},{"key":"9622_CR22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351:427\u201337.","journal-title":"N Engl J Med"},{"key":"9622_CR23","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004; 292:1317\u201325.","journal-title":"JAMA"},{"key":"9622_CR24","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66646-9","volume":"365","author":"MO Leach","year":"2005","unstructured":"Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 2005; 365:1769\u201378.","journal-title":"Lancet"},{"key":"9622_CR25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jmri.20752","volume":"24","author":"CD Lehman","year":"2006","unstructured":"Lehman CD. Role of MRI in screening women at high risk for breast cancer. J Magn Reson Imaging 2006; 24:964\u201370.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"9622_CR26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jnci\/89.3.227","volume":"89","author":"DA Berry","year":"1997","unstructured":"Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997; 89(3):227\u201338.","journal-title":"J Natl Cancer Inst"},{"key":"9622_CR27","unstructured":"National Cancer Institute Breast Cancer Risk Assessment Tool (2007) Available: http:\/\/www.cancer.gov\/bcrisktool (accessed July 27 2007)."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9622-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-007-9622-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9622-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:27:13Z","timestamp":1572953233000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-007-9622-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,17]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["9622"],"URL":"https:\/\/doi.org\/10.1245\/s10434-007-9622-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,17]]}}}